Loading...
Loading...
India's tobramycin imports from UNITED STATES total $498.0K across 61 shipments from 15 foreign suppliers. JUPITER RESEARCH SERVICES INC leads with $294.0K in import value; the top 5 suppliers together control 79.1% of this origin. Leading Indian buyers include MICRO LABS LIMITED. This corridor reflects India's pharmaceutical import demand for tobramycin — a diversified sourcing base with multiple active suppliers from UNITED STATES.

JUPITER RESEARCH SERVICES INC is the leading Tobramycin supplier from UNITED STATES to India, with import value of $294.0K across 3 shipments. The top 5 suppliers — JUPITER RESEARCH SERVICES INC, ESPEE BIOPHARMA FINECHEM LLC, RAFF & HALL PHARMACY, M/S. SUN PHARMACEUTICAL INDUSTRIES, AMSTERDAM PHARMA(APTEKA RX INC.) — collectively account for 79.1% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | JUPITER RESEARCH SERVICES INC | $294.0K | 3 | 59.0% |
| 2 | ESPEE BIOPHARMA FINECHEM LLC | $31.3K | 5 | 6.3% |
| 3 | RAFF & HALL PHARMACY | $27.5K | 4 | 5.5% |
| 4 | M/S. SUN PHARMACEUTICAL INDUSTRIES | $20.6K | 6 | 4.1% |
| 5 | AMSTERDAM PHARMA(APTEKA RX INC.) | $20.5K | 1 | 4.1% |
| 6 | SPRING BIO SOLUTION | $16.5K | 2 | 3.3% |
| 7 | ESPEE BIOPHARMA & FINECHEM LLC | $15.2K | 5 | 3.0% |
| 8 | NEWLIFE MEDICALS USA INC | $13.2K | 2 | 2.7% |
| 9 | RAFF HALL PHARMACY | $12.6K | 6 | 2.5% |
| 10 | NEW LIFE MEDICALS (USA) INC., | $7.4K | 1 | 1.5% |
| 11 | ESPEE BIOPHARMA AND FINECHEM LLC | $6.7K | 1 | 1.4% |
| 12 | NEW LIFE MEDICALS(USA).INC, | $6.2K | 1 | 1.3% |
| 13 | NEW LIFE MEDICALS USA INC | $4.0K | 3 | 0.8% |
| 14 | AMSTERDAM PHARMA(APTEKA RX INC) | $3.7K | 1 | 0.7% |
| 15 | Raff & Hall Pharmacy | $3.7K | 3 | 0.7% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MICRO LABS LIMITED | $305.8K | 7 | 61.4% |
| 2 | MICRO LABS LTD | $33.1K | 3 | 6.6% |
| 3 | ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI | $24.1K | 4 | 4.8% |
| 4 | AUROBINDO PHARMA LTD | $23.1K | 5 | 4.6% |
| 5 | SUN PHARMACEUTICAL MEDICARE LIMITED | $20.6K | 6 | 4.1% |
| 6 | DR.REDDY'S LABORATORIES LTD | $20.5K | 1 | 4.1% |
| 7 | FDC LIMITED | $18.9K | 6 | 3.8% |
| 8 | MANKIND PHARMA LIMITED | $17.9K | 12 | 3.6% |
| 9 | INDOCO REMEDIES LIMITED | $15.1K | 5 | 3.0% |
| 10 | ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED | $6.7K | 1 | 1.4% |
| 11 | HETERO LABS LIMITED | $4.0K | 3 | 0.8% |
| 12 | MANKIND PHARMA LTD | $3.4K | 1 | 0.7% |
| 13 | AJANTA PHARMA LIMITED | $2.4K | 1 | 0.5% |
| 14 | CAPLIN STERILES LIMITED | $1.3K | 1 | 0.3% |
| 15 | HETERO LABS LIMITED | $944 | 1 | 0.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Tobramycin suppliers from UNITED STATES to India include JUPITER RESEARCH SERVICES INC, ESPEE BIOPHARMA FINECHEM LLC, RAFF & HALL PHARMACY. The leading supplier is JUPITER RESEARCH SERVICES INC with import value of $294.0K USD across 3 shipments. India imported Tobramycin worth $498.0K USD from UNITED STATES in total across 61 shipments.
India imported Tobramycin worth $498.0K USD from UNITED STATES across 61 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Tobramycin sourced from UNITED STATES include MICRO LABS LIMITED, MICRO LABS LTD, ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI. The largest buyer is MICRO LABS LIMITED with $305.8K in imports across 7 shipments.
The total value of Tobramycin imports from UNITED STATES to India is $498.0K USD, across 61 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
61 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists